[1]王国富.贝伐珠单抗联合化学药物治疗晚期胃癌的疗效观察[J].医学信息,2018,31(08):128-130.[doi:10.3969/j.issn.1006-1959.2018.08.043]
　WANG Guo-fu.Efficacy of Bevacizumab Combined with Chemical Drugs in the Treatment of Advanced Gastric Cancer[J].Journal of Medical Information,2018,31(08):128-130.[doi:10.3969/j.issn.1006-1959.2018.08.043]
点击复制

贝伐珠单抗联合化学药物治疗晚期胃癌的疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
128-130
栏目:
药物与临床
出版日期:
2018-04-15

文章信息/Info

Title:
Efficacy of Bevacizumab Combined with Chemical Drugs in the Treatment of Advanced Gastric Cancer
文章编号:
1006-1959（2018）08-0128-03
作者:
王国富
黑龙江省佳木斯市中心医院肿瘤内科，黑龙江 佳木斯 154002
Author(s):
WANG Guo-fu
Department of Oncology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
贝伐珠单抗联合化学药物; 晚期胃癌; 疗效观察; 安全性评价
Keywords:
Key words：Bevacizumab combined with chemical drugs; Advanced gastric cancer; Efficacy observation; Safety evaluation
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2018.08.043
文献标志码:
A
摘要:
目的 研究贝伐珠单抗联合化学药物应用于晚期胃癌患者的安全性评价与临床疗效观察。方法 选取我院2014年1月~2017年6月收治的64例晚期胃癌患者作为研究对象，随机均分为联合组和化疗组,各32例。化疗组行常规化学药物治疗采用奥沙利铂、亚叶酸钙和氟尿嘧啶的治疗方法，实验组在常规治疗的基础上行贝伐珠单抗联合治疗，即静脉推注7.5 mg/kg的贝伐珠单抗。两组均连续治疗3个疗程，每个疗程的时长为21 d。比较两组患者治疗前后血清肿瘤标志物水平、药物毒副作用情况和近期的综合疗效观察及患者生存质量情况。结果 血清肿瘤标志物水平治疗前＞化疗组＞联合组，差异有统计学意义（P＜0.05），联合组疗效、生存质量高于化疗组，差异有统计学意义（P＜0.05）。联合组患者无毒副作用发生率与联合组，差异无统计学意义（P＞0.05）。结论 采用贝伐珠单抗联合化学药物治疗晚期胃癌患者有显著的临床疗效，不增加毒副作用，值得在临床上推广使用。
Abstract:
Abstract：Objective To study the safety evaluation and clinical efficacy of bevacizumab combined with chemical drugs in patients with advanced gastric cancer.Methods 64 patients with advanced gastric cancer admitted in our hospital from January 2014 to June 2017 were randomly divided into combined group and chemotherapy group(32 cases each).The chemotherapy group was treated with oxaliplatin, calcium folinate and fluorouracil.The experimental group was treated with bevacizumab on the basis of routine therapy, that is, the bevacizumab of 7.5 mg/kg was injected intravenously.The two groups were treated continuously for 3 courses,the duration of each course was 21 d.The levels of serum tumor markers,the side effects of drugs,the recent comprehensive efficacy and the quality of life of the two groups before and after treatment were compared.Results The level of serum tumor markers before treatment> chemotherapy group>combined group,the difference was statistically significant(P<0.05).The curative effect and quality of life of the combined group were higher than that of the chemotherapy group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of no toxic side effects between the combined group and the combined group(P>0.05). Conclusion The combination of bevacizumab and chemotherapeutic drugs is effective in the treatment of advanced gastric cancer without increasing side effects and is worth popularizing in clinic.

参考文献/References:

[1]李跃军,肖茂良,李春球,等.奥沙利铂联合替吉奥方案治疗晚期胃癌的临床观察[J].重庆医学,2011，40(5):2581.
[2]陈敏华,申维玺,夏俊贤,等.DCF方案一线化疗后替吉奥维持治疗晚期胃癌[J].南方医科大学学报,2014,13(7):1507.
[3]李建璜,李斌,蒋海荣,等.紫杉醇脂质体联合顺铂及5-氟尿嘧啶治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2011,33(3):299.
[4]付红伟,孙涛,井明晰,等.贝伐珠单抗联合化学药物治疗晚期胃癌的疗效观察[J].国际病理科学与临床杂志,2013,33(1):42.
[5]吕晓娴,刘冰,张瑞丽.血清cEA和cA199及cA724联合检测对胃癌诊断的临床意义[J].中国肿瘤临床与康复,2007,14(1):26.
[6]丁志祥,王梅,钱高潮,等.胃癌患者血清CEA、CA19-9和CA72-4联合检测的临床意义[J].江苏大学学报:医学版,2011,21(6):488.
[7]孙嘉琦,姜雷,袁文臻,等.贝伐珠单抗联合化疗治疗晚期胃癌的 Meta 分析[J].肿瘤,2016,36(1):60-69.
[8]于韶荣,史美祺,夏国豪,等.贝伐珠单抗联合含铂化疗方案一线治疗晚期非鳞 NSCLC 疗效分析[J]. 实用肿瘤杂志,2015,30(5):418-422.
[9]胡青,肖志华.贝伐珠单抗联合多西紫杉醇,5-FU 以及顺铂化疗治疗晚期胃癌的疗效观察[J].实用癌症杂志,2015 (02): 225-227,231.
[10]王丽红,刘迎,杜晓林.贝伐珠单抗联合化疗方案用于晚期胃癌的临床观察[J].中国药房,2016,27(23): 3246-3248.

相似文献/References:

[1]王 平,苏志红.参芪扶正注射液辅助治疗晚期胃癌的效果[J].医学信息,2019,32(24):50.[doi:10.3969/j.issn.1006-1959.2019.24.016]
　WANG Ping,SU Zhi-hong.Effect of Shenqi Fuzheng Injection on Adjuvant Treatment of Advanced Gastric Cancer[J].Journal of Medical Information,2019,32(08):50.[doi:10.3969/j.issn.1006-1959.2019.24.016]
[2]刘晓亮.mEOX联合同步放疗对晚期胃癌患者血清肿瘤标记物及生存期的影响[J].医学信息,2020,33(04):112.[doi:10.3969/j.issn.1006-1959.2020.04.034]
　LIU Xiao-liang.Effect of mEOX Combined with Concurrent Radiotherapy on Serum Tumor Markers and Survival of Patients with Advanced Gastric Cancer[J].Journal of Medical Information,2020,33(08):112.[doi:10.3969/j.issn.1006-1959.2020.04.034]
[3]那文秀.奥沙利铂联合卡培他滨治疗晚期胃癌的疗效[J].医学信息,2020,33(06):144.[doi:10.3969/j.issn.1006-1959.2020.06.046]
　NA Wen-xiu.Efficacy of Oxaliplatin Combined with Capecitabine in the Treatment of Advanced Gastric Cancer[J].Journal of Medical Information,2020,33(08):144.[doi:10.3969/j.issn.1006-1959.2020.06.046]

更新日期/Last Update: 2018-04-15